Anthem Blue Cross (HMO, PPO, EPO) |
Onureg (azacitidine) |
Drugs for Cancer : Drugs for Cancer |
- Prior Authorization: Lupus Nephritis:
Documented Diagnosis: Yes
Duration: 12 Month(s)
Reauthorization Required: Yes
Systemic Lupus Erythematosus (SLE): Documented Diagnosis: Yes
Medical Test Required: Yes
Duration: 12 Month(s)
Reauthorization Required: Yes
- Orally administered anticancer medication.
- Anemia:
Duration: 6 Month(s)
Specialist Required: Yes
Documented Diagnosis: Yes
Medical Test Required: Yes
Reauthorization Required: Yes
Dialysis status: Patients on dialysis and not on dialysis
Initial Therapy HgbHCT Requirements: Hgb < 10g/dL
Initial Therapy Iron Stores Requirements: serum ferritin >= 100 ng/mL AND TSAT >= 20%
Discontinuation requirements: No
Reauthorization Requirements Iron Stores: serum ferritin >= 100 ng/mL AND TSAT >= 20%
Anemia due to Chemotherapy: Age Requirement: >= 18
Duration: 6 Month(s)
Specialist Required: Yes
Documented Diagnosis: Yes
Medical Test Required: Yes
Specialist Type(s): 1 of Hematologist;Oncologist
Reauthorization Required: No
Duration of Reauthorization: <= 6 month(s)
Initial Therapy HgbHCT Requirements: Hgb < 10g/dL
Initial Therapy Iron Stores Requirements: serum ferritin >= 100 ng/mL AND TSAT >= 20%
Diagnosis Types: concomitant myelosuppresive chemotherapy
Dose Increase Requirements: No
Discontinuation requirements: No
Reauthorization Requirements HgbHCT: 2 of Hgb <= 10 g/dL;Must show response to therapy with increase in Hgb >= 1 g/dL
Reauthorization Requirements Iron Stores: serum ferritin >= 100 ng/mL AND TSAT >= 20%
- ST_APPLIES
|